These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

805 related articles for article (PubMed ID: 19834490)

  • 1. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
    Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
    Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.
    Szabo E; Schneider H; Seystahl K; Rushing EJ; Herting F; Weidner KM; Weller M
    Neuro Oncol; 2016 Sep; 18(9):1242-52. PubMed ID: 27009237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGFR1 and VEGFR2 in Alzheimer's Disease.
    Harris R; Miners JS; Allen S; Love S
    J Alzheimers Dis; 2018; 61(2):741-752. PubMed ID: 29226875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
    Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
    Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal compound farnesiferol C exerts antiangiogenic and antitumor activity and targets multiple aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) signaling cascades.
    Lee JH; Choi S; Lee Y; Lee HJ; Kim KH; Ahn KS; Bae H; Lee HJ; Lee EO; Ahn KS; Ryu SY; Lü J; Kim SH
    Mol Cancer Ther; 2010 Feb; 9(2):389-99. PubMed ID: 20103598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced β‑2‑glycoprotein І inhibits hypoxia‑induced retinal angiogenesis in neonatal mice through the vascular endothelial growth factor pathway.
    Liu H; Zhou S; Denyer G; Meng Z; Chen R; Lv L; Li C; Yu D; Yu P
    Mol Med Rep; 2015 Feb; 11(2):1025-30. PubMed ID: 25374014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
    Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
    World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis.
    Bruns AF; Bao L; Walker JH; Ponnambalam S
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1193-7. PubMed ID: 19909245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium.
    Dellinger MT; Brekken RA
    PLoS One; 2011; 6(12):e28947. PubMed ID: 22174934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling.
    Awasthi N; Schwarz MA; Verma V; Cappiello C; Schwarz RE
    Lab Invest; 2009 Jan; 89(1):38-46. PubMed ID: 19002109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent.
    Shin SJ; Hwang JW; Ahn JB; Rha SY; Roh JK; Chung HC
    Invest New Drugs; 2013 Feb; 31(1):1-13. PubMed ID: 22539090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis.
    Bruns AF; Herbert SP; Odell AF; Jopling HM; Hooper NM; Zachary IC; Walker JH; Ponnambalam S
    Traffic; 2010 Jan; 11(1):161-74. PubMed ID: 19883397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
    Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
    Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
    Wang J; Yang L; Liang F; Chen Y; Yang G
    J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
    Shibuya M
    J Biochem Mol Biol; 2006 Sep; 39(5):469-78. PubMed ID: 17002866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
    Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
    J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
    Ganta VC; Choi M; Kutateladze A; Annex BH
    Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.